News and information

On 14 September 2016, The Netherlands completed the ratification process of the Unified Patent Court agreement, by depositing its instrument of ratification at the Council of the European Union in Brussels.

Now that the votes have been counted, it is clear that the UK electorate has voted to leave the EU. The referendum result is not legally binding, but there is no serious doubt that the UK government will follow the result and within some months start the procedure to leave the EU, and that the UK Parliament will not block an EU exit.

It’s easier to experience what virtual reality is than to describe it. It’s a question of putting on the headset, pulling on the gloves and suddenly you’re being attacked from all sides by flying aliens. That interaction between the real and the virtual world, is managed by the Manus.

According to The Global Intellectual Property Index 5th Report (GIPI5) by law firm Taylor Wessing, the Netherlands is an IP leader. The report, released June 14, compares IP regimes in 43 jurisdictions based on their accessibility, ease of enforcing rights and legal framework.

Consumers come across food and drink products every day, and several times a day they must choose between the products of various suppliers. The distinguishing power and brand experience of these products and their packaging plays a big role in these choices.

The IAM Patent 1000 2016: The World’s Leading Patent Professionals identifies the top patent practitioners in key jurisdictions around the globe. In this new edition, 8 patent attorneys of NLO have received a ‘highly recommended’ ranking for ‘Prosecution’.

'A top molecule' is how Sander van Berkel describes the discovery of BCN, made in 2010 at Radboud University in Nijmegen. Now this molecule is the basis for Synaffix, a young biotech company in Oss. "The most important thing that we do is trying to bring a cure for cancer a step closer."

NLO’s patent attorneys Emil Pot and Thea van der Wijk are featured in BioVox’ whitepaper, in which the challenges and opportunities of in vitro diagnostics (IVD) in Europe and the US are being discussed.

Knowledge for Growth is Europe's leading regional biotech and life sciences convention attended by more than 1.100 participants from > 330 life sciences companies & organisations.

NLO is Golden Sponsor and our experts will be present during the day at booth 31.

An article by Caroline Pallard (NLO) and Armand Killan (Bird&Bird) regarding the patentability of second or further medical use of substances or compositions, focusing on the Swiss-type claim and its successor, the purpose-limited product claim, as introduced by the EPC.